CN1742623A - 透明质酸磷脂复合物及其制备方法 - Google Patents

透明质酸磷脂复合物及其制备方法 Download PDF

Info

Publication number
CN1742623A
CN1742623A CNA2005100440676A CN200510044067A CN1742623A CN 1742623 A CN1742623 A CN 1742623A CN A2005100440676 A CNA2005100440676 A CN A2005100440676A CN 200510044067 A CN200510044067 A CN 200510044067A CN 1742623 A CN1742623 A CN 1742623A
Authority
CN
China
Prior art keywords
phosphatide
hyaluronic acid
class
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005100440676A
Other languages
English (en)
Chinese (zh)
Inventor
凌沛学
黄思玲
娄红祥
张天民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNA2005100440676A priority Critical patent/CN1742623A/zh
Publication of CN1742623A publication Critical patent/CN1742623A/zh
Priority to PCT/CN2006/001652 priority patent/WO2007006232A1/zh
Priority to JP2008520696A priority patent/JP5114397B2/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CNA2005100440676A 2005-07-13 2005-07-13 透明质酸磷脂复合物及其制备方法 Pending CN1742623A (zh)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CNA2005100440676A CN1742623A (zh) 2005-07-13 2005-07-13 透明质酸磷脂复合物及其制备方法
PCT/CN2006/001652 WO2007006232A1 (fr) 2005-07-13 2006-07-12 Complexe de phospholipide et d’acide hyaluronique et procédé de préparation
JP2008520696A JP5114397B2 (ja) 2005-07-13 2006-07-12 ヒアルロン酸リン脂質複合体及びその調製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2005100440676A CN1742623A (zh) 2005-07-13 2005-07-13 透明质酸磷脂复合物及其制备方法

Publications (1)

Publication Number Publication Date
CN1742623A true CN1742623A (zh) 2006-03-08

Family

ID=36138272

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005100440676A Pending CN1742623A (zh) 2005-07-13 2005-07-13 透明质酸磷脂复合物及其制备方法

Country Status (3)

Country Link
JP (1) JP5114397B2 (cg-RX-API-DMAC7.html)
CN (1) CN1742623A (cg-RX-API-DMAC7.html)
WO (1) WO2007006232A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118766082A (zh) * 2023-12-29 2024-10-15 黑龙江飞鹤乳业有限公司 组合物、食品及其应用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2921253B1 (fr) * 2007-09-26 2012-11-16 Lvmh Rech Composition cosmetique sous la forme d'une emulsion comprenant une phase aqueuse continue et une phase grasse dispersee et son procede de preparation
CA2703532C (en) * 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
CN121370848A (zh) * 2025-12-25 2026-01-23 哈药集团技术中心 一种含有右莰醇的药物组合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ320006A (en) * 1995-10-23 2001-12-21 Meditech Res Ltd An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction
JP3687277B2 (ja) * 1997-06-10 2005-08-24 サンスター株式会社 美白化粧料
US7141552B2 (en) * 2000-01-10 2006-11-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
JP4521809B2 (ja) * 2004-04-16 2010-08-11 生化学工業株式会社 歯周疾患の検定方法および検定用キット
US8178129B2 (en) * 2004-11-02 2012-05-15 Tel-Aviv University Future Technology Development L.P. Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their use for diagnostic and therapy
ITPD20050146A1 (it) * 2005-05-20 2006-11-21 Fidia Farmaceutici Fillers riassorbibili costituiti da liposomi e acido ialuronico e o suoi derivati

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118766082A (zh) * 2023-12-29 2024-10-15 黑龙江飞鹤乳业有限公司 组合物、食品及其应用

Also Published As

Publication number Publication date
WO2007006232A1 (fr) 2007-01-18
JP2009500503A (ja) 2009-01-08
JP5114397B2 (ja) 2013-01-09

Similar Documents

Publication Publication Date Title
US9968634B2 (en) Techniques and systems for treatment of neuropathic pain and other indications
US10034898B2 (en) Methods and systems for treatment of inflammatory diseases with nitric oxide
JP7443443B2 (ja) 関節を治療するための組成物及びキット
CN103547258B (zh) 局部一氧化氮系统及其使用方法
CN102985091B (zh) 使用抗微生物肽螯合化合物治疗皮肤疾病和异常的组合物和方法
JP6574228B2 (ja) 局所麻酔薬のデポー製剤及びその調製方法
US9387159B2 (en) Treatment of skin, including aging skin, to improve appearance
US8871260B2 (en) Methods and compositions for muscular and neuromuscular diseases
AU2002324481B2 (en) Emu-based formulations for wound treatment related application information
JPH06508155A (ja) 定義された脂質系を含有する薬剤組成物
EP3386496B1 (fr) Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
US20090170808A1 (en) Oral agent for improving and protecting the function of joint comprising hyaluronic acid-phospholipid complexes
KR102784991B1 (ko) 연어추출물을 함유한 피부 재생용 화장품 조성물 및 그 제조방법
CN112870154B (zh) 兽用复方塞来昔布纳米脂质体凝胶及其制备方法
US20050070500A1 (en) Method of modulating release of saccharides and uses thereof
EP0619741A1 (fr) Composition lipidique polaire d'origine vegetale
JP5114397B2 (ja) ヒアルロン酸リン脂質複合体及びその調製法
US20230364129A1 (en) Topical compositions
US9051456B2 (en) Agent for drug clearance and accelerator for drug clearance
BR112020009041A2 (pt) formulações de álcool para seda

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication